Literature DB >> 26657955

Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?

Rocco G Gogliotti1,2, P Jeffrey Conn1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26657955      PMCID: PMC4677143          DOI: 10.1038/npp.2015.259

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  7 in total

1.  Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome.

Authors:  Jorge Castro; Rodrigo I Garcia; Showming Kwok; Abhishek Banerjee; Jeremy Petravicz; Jonathan Woodson; Nikolaos Mellios; Daniela Tropea; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

2.  NNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndrome.

Authors:  Robert M J Deacon; Larry Glass; Mike Snape; Michael J Hurley; Francisco J Altimiras; Rodolfo R Biekofsky; Patricia Cogram
Journal:  Neuromolecular Med       Date:  2015-01-23       Impact factor: 3.843

3.  Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.

Authors:  Omar S Khwaja; Eugenia Ho; Katherine V Barnes; Heather M O'Leary; Luis M Pereira; Yaron Finkelstein; Charles A Nelson; Vanessa Vogel-Farley; Geneva DeGregorio; Ingrid A Holm; Umakanth Khatwa; Kush Kapur; Mark E Alexander; Deirdre M Finnegan; Nicole G Cantwell; Alexandra C Walco; Leonard Rappaport; Matt Gregas; Raina N Fichorova; Michael W Shannon; Mriganka Sur; Walter E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-12       Impact factor: 11.205

4.  The contribution of de novo coding mutations to autism spectrum disorder.

Authors:  Ivan Iossifov; Brian J O'Roak; Stephan J Sanders; Michael Ronemus; Niklas Krumm; Dan Levy; Holly A Stessman; Kali T Witherspoon; Laura Vives; Karynne E Patterson; Joshua D Smith; Bryan Paeper; Deborah A Nickerson; Jeanselle Dea; Shan Dong; Luis E Gonzalez; Jeffrey D Mandell; Shrikant M Mane; Michael T Murtha; Catherine A Sullivan; Michael F Walker; Zainulabedin Waqar; Liping Wei; A Jeremy Willsey; Boris Yamrom; Yoon-ha Lee; Ewa Grabowska; Ertugrul Dalkic; Zihua Wang; Steven Marks; Peter Andrews; Anthony Leotta; Jude Kendall; Inessa Hakker; Julie Rosenbaum; Beicong Ma; Linda Rodgers; Jennifer Troge; Giuseppe Narzisi; Seungtai Yoon; Michael C Schatz; Kenny Ye; W Richard McCombie; Jay Shendure; Evan E Eichler; Matthew W State; Michael Wigler
Journal:  Nature       Date:  2014-10-29       Impact factor: 69.504

5.  Synaptic, transcriptional and chromatin genes disrupted in autism.

Authors:  Silvia De Rubeis; Xin He; Arthur P Goldberg; Christopher S Poultney; Kaitlin Samocha; A Erucment Cicek; Yan Kou; Li Liu; Menachem Fromer; Susan Walker; Tarinder Singh; Lambertus Klei; Jack Kosmicki; Fu Shih-Chen; Branko Aleksic; Monica Biscaldi; Patrick F Bolton; Jessica M Brownfeld; Jinlu Cai; Nicholas G Campbell; Angel Carracedo; Maria H Chahrour; Andreas G Chiocchetti; Hilary Coon; Emily L Crawford; Sarah R Curran; Geraldine Dawson; Eftichia Duketis; Bridget A Fernandez; Louise Gallagher; Evan Geller; Stephen J Guter; R Sean Hill; Juliana Ionita-Laza; Patricia Jimenz Gonzalez; Helena Kilpinen; Sabine M Klauck; Alexander Kolevzon; Irene Lee; Irene Lei; Jing Lei; Terho Lehtimäki; Chiao-Feng Lin; Avi Ma'ayan; Christian R Marshall; Alison L McInnes; Benjamin Neale; Michael J Owen; Noriio Ozaki; Mara Parellada; Jeremy R Parr; Shaun Purcell; Kaija Puura; Deepthi Rajagopalan; Karola Rehnström; Abraham Reichenberg; Aniko Sabo; Michael Sachse; Stephan J Sanders; Chad Schafer; Martin Schulte-Rüther; David Skuse; Christine Stevens; Peter Szatmari; Kristiina Tammimies; Otto Valladares; Annette Voran; Wang Li-San; Lauren A Weiss; A Jeremy Willsey; Timothy W Yu; Ryan K C Yuen; Edwin H Cook; Christine M Freitag; Michael Gill; Christina M Hultman; Thomas Lehner; Aaarno Palotie; Gerard D Schellenberg; Pamela Sklar; Matthew W State; James S Sutcliffe; Christiopher A Walsh; Stephen W Scherer; Michael E Zwick; Jeffrey C Barett; David J Cutler; Kathryn Roeder; Bernie Devlin; Mark J Daly; Joseph D Buxbaum
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

Review 6.  The challenges of clinical trials in fragile X syndrome.

Authors:  Sébastien Jacquemont; Elizabeth Berry-Kravis; Randi Hagerman; Florian von Raison; Fabrizio Gasparini; George Apostol; Mike Ufer; Vincent Des Portes; Baltazar Gomez-Mancilla
Journal:  Psychopharmacology (Berl)       Date:  2013-10-31       Impact factor: 4.530

7.  A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome.

Authors:  Miriam Kron; Min Lang; Ian T Adams; Michael Sceniak; Frank Longo; David M Katz
Journal:  Dis Model Mech       Date:  2014-09       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.